ArticleIDCases2026
Clinical characteristics of
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Acute pulmonary infection caused by Methods: A retrospective analysis was conducted on five patients diagnosed with TW pneumonia from 2021 to 2023 in Changzhou No. 2 People's Hospital. The study focused on clinical symptoms, imaging characteristics, diagnostic methods, and treatment approaches. Results: Patients aged 35-65 years had underlying diseases and presented with fever, cough, expectoration, and chest tightness. Laboratory tests showed white blood cells, procalcitonin, C-reactive protein, and erythrocyte sedimentation rate increased, and the patients had anemia and hypoalbuminemia. Chest CT showed nodular lesions, cavities and patchy shadows. TW was detected in bronchoalveolar lavage fluid (BALF) by metagenomic next-generation sequencing (mNGS). Four patients received ceftriaxone combined with doxycycline or compound sulfamethoxazole tablets, while one treated empirically with cefotetan. All patients showed significant improvement. Conclusion: TW pneumonia often occurs in patients with underlying diseases, and immunocompromised patients have more severe lung damage. Most chest CT shows nodular lesions with atypical distribution and shape. Early diagnosis requires relies on mNGS, and treatment mainly bases on the third-generation cephalosporin combined with tetracycline or sulfonamides. Sequential therapy with sulfamethoxazole and clarithromycin is effective, and close follow-up needs to determine the total course of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.